메뉴 건너뛰기




Volumn 15, Issue 4, 2007, Pages 1679-1693

Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists

Author keywords

Integrin; Oral availability; VLA 4

Indexed keywords

4 [1 [3 BROMO 4 [N' (2 BROMOPHENYL)UREIDO]PHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 BROMO 4 [N' (2 CHLOROPHENYL)UREIDO]PHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 BROMO 4 [N' (2 METHYLPHENYL)UREIDO]PHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 CHLORO 4 [N' (2 CHLOROPHENYL)UREIDO]PHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 CHLORO 4 [N' (2 METHYLPHENYL)UREIDO]PHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 ETHYL 4 [N' (2 METHYLPHENYL)UREIDO] 3 METHYLPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [3 ISOPROPYL 4 [N' (2 METHYLPHENYL)UREIDO] 3 METHYLPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 BROMOPHENYL)UREIDO] 3 CHLOROPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 BROMOPHENYL)UREIDO] 3 METHOXYPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 BROMOPHENYL)UREIDO] 3 METHYLPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 CHLOROPHENYL)UREIDO] 3 METHOXYPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 CHLOROPHENYL)UREIDO] 3 METHYLPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [1 [4 [N' (2 METHYLPHENYL)UREIDO] 3 TRIFLUOROMETHYLPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [FLUORO 1 [3 METHOXY 4 [N' (2 TRIFLUOROMETHYLPHENYL)UREIDO] 3 METHOXYPHENYLACETYL]FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [FLUORO 1 [3 METHYL 4 [N' (2 METHYLPHENYL)UREIDO] 3 METHOXYPHENYLACETYL]FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [FLUORO 1 [4 [N' (2 ISOPROPYLPHENYL)UREIDO] 3 METHOXYPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; 4 [FLUORO 1 [4 [N' (2 METHOXYPHENYL)UREIDO] 3 METHOXYPHENYLACETYL] FLUOROPYRROLIDINYLMETHOXY]BENZOIC ACID; BENZENE; BENZOIC ACID DERIVATIVE; BROMINE; CHLORINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UREA DERIVATIVE; VERY LATE ACTIVATION ANTIGEN 4 ANTAGONIST;

EID: 33847770256     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.12.006     Document Type: Article
Times cited : (15)

References (35)
  • 1
    • 0023666065 scopus 로고
    • Hynes R.O. Cell 48 (1987) 549
    • (1987) Cell , vol.48 , pp. 549
    • Hynes, R.O.1
  • 21
    • 33847796459 scopus 로고    scopus 로고
    • Elan-Biogen official home page: http://www.tysabri.com/.
  • 25
    • 33847778977 scopus 로고    scopus 로고
    • Castro, A. C.; Lin, K.-C. 213th ACS National Meeting (Apr. 13-17, San Francisco), 1997; Abstraction MEDI 077.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.